The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness

Frontiers in Behavioral Neuroscience

Volumn , Issue FEBRUARY 2012, 2012, Pages

  Campolongo, P ^a   Ratano, P ^a   Manduca, A ^b   Scattoni, M L ^c   Palmery, M ^a   Trezza, V ^b   Cuomo, V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AM404; Cannabinoid system; Cognition; Emotionality; Endocannabinoids; Short term memory

Indexed keywords

N (4 HYDROXYPHENYL)ARACHIDONAMIDE;

ANIMAL EXPERIMENT; AROUSAL; AVERSIVE BEHAVIOR; COGNITION; CONTROLLED STUDY; DRUG EFFECT; EMOTIONALITY; LOCOMOTION; MALE; MEMORY; MENTAL PERFORMANCE; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; RAT; REVIEW; SPATIAL DISCRIMINATION; VISUAL MEMORY;

EID: 84885295742     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2012.00011     Document Type: Article

References (120)

1. Abush, H., and Akirav, I. (2010). Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20, 1126-1138.
2. Akirav, I. (2011). The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front Behav Neurosci 5, 34.
3. Atsak, P., Roozendaal, B., and Campolongo, P. (2011). Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience.
4. Barna, I., Soproni, K., Arszovszki, A., Csabai, K., and Haller, J. (2007). WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids. Behav Pharmacol 18, 515-520.
5. Beltramo, M., and Piomelli, D. (2000). Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11, 1231-1235.
6. Beltramo, M., Stella, N., Calignano, A., Lin, S.Y., Makriyannis, A., and Piomelli, D. (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277, 1094-1097.
7. Biegler, R., and Morris, R. (1996). Landmark stability: studies exploring whether the perceived stability of the environment influences spatial representation. J Exp Biol 199, 187-193.
8. Bisogno, T., and Di Marzo, V. (2010). Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders. CNS Neurol Disord Drug Targets 9, 564-573.
9. Blanchard, D.C., Griebel, G., and Blanchard, R.J. (2001). Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 25, 205-218.
10. Bolla, K.I., Brown, K., Eldreth, D., Tate, K., and Cadet, J.L. (2002). Dose-related neurocognitive effects of marijuana use. Neurology 59, 1337-1343.
11. Bortolato, M., Campolongo, P., Mangieri, R.A., Scattoni, M.L., Frau, R., Trezza, V., La Rana, G., Russo, R., Calignano, A., Gessa, G.L., Cuomo, V., and Piomelli, D. (2006). Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31, 2652-2659.
12. Boucher, A.A., Hunt, G.E., Micheau, J., Huang, X., Mcgregor, I.S., Karl, T., and Arnold, J.C. (2011). The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. Int J Neuropsychopharmacol 14, 631-643.
13. Boucher, A.A., Vivier, L., Metna-Laurent, M., Brayda-Bruno, L., Mons, N., Arnold, J.C., and Micheau, J. (2009). Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain. Behav Pharmacol 20, 45-55.
14. Breivogel, C.S., and Childers, S.R. (1998). The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 5, 417-431.
15. Campolongo, P., Roozendaal, B., Trezza, V., Cuomo, V., Astarita, G., Fu, J., Mcgaugh, J.L., and Piomelli, D. (2009a). Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. Proc Natl Acad Sci U S A 106, 8027-8031.
16. Campolongo, P., Roozendaal, B., Trezza, V., Hauer, D., Schelling, G., Mcgaugh, J.L., and Cuomo, V. (2009b). Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci U S A 106, 4888-4893.
17. Campolongo, P., Trezza, V., Palmery, M., Trabace, L., and Cuomo, V. (2009c). Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. Int Rev Neurobiol 85, 117-133.
18. Campolongo, P., Trezza, V., Ratano, P., Palmery, M., and Cuomo, V. (2011). Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl) 214, 5-15.
19. Clarke, J.R., Rossato, J.I., Monteiro, S., Bevilaqua, L.R., Izquierdo, I., and Cammarota, M. (2008). Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Neurobiol Learn Mem 90, 374-381.
20. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A., and Gilula, N.B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87.
21. Crawley, J.N. (1985). Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9, 37-44.
22. Curran, H.V., Brignell, C., Fletcher, S., Middleton, P., and Henry, J. (2002). Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) 164, 61-70.
23. D'souza, D.C., Sewell, R.A., and Ranganathan, M. (2009). Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 259, 413-431.
24. De Bartolo, P., Cutuli, D., Ricceri, L., Gelfo, F., Foti, F., Laricchiuta, D., Scattoni, M.L., Calamandrei, G., and Petrosini, L. (2010). Does age matter? Behavioral and neuroanatomical effects of neonatal and adult basal forebrain cholinergic lesions. J Alzheimers Dis. 20, 207-227.
25. De Oliveira Alvares, L., Engelke, D.S., Diehl, F., Scheffer-Teixeira, R., Haubrich, J., De Freitas Cassini, L., Molina, V.A., and Quillfeldt, J.A. (2010). Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memory. Learn Mem 17, 202-209.
26. De Oliveira Alvares, L., Genro, B.P., Diehl, F., and Quillfeldt, J.A. (2008). Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. Neurobiol Learn Mem 90, 1-9.
27. De Quervain, D.J., Aerni, A., Schelling, G., and Roozendaal, B. (2009). Glucocorticoids and the regulation of memory in health and disease. Front Neuroendocrinol 30, 358-370.
28. Deadwyler, S.A., Goonawardena, A.V., and Hampson, R.E. (2007). Short-term memory is modulated by the spontaneous release of endocannabinoids: evidence from hippocampal population codes. Behav Pharmacol 18, 571-580.
29. Desarnaud, F., Cadas, H., and Piomelli, D. (1995). Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem 270, 6030-6035.
30. Di Marzo, V. (1998). 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1392, 153-175.
31. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.C., and Piomelli, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
32. Di Marzo, V., and Matias, I. (2005). Endocannabinoid control of food intake and energy balance. Nat Neurosci 8, 585-589.
33. Egerton, A., Allison, C., Brett, R.R., and Pratt, J.A. (2006). Cannabinoids and prefrontal cortical function: insights from preclinical studies. Neurosci Biobehav Rev 30, 680-695.
34. Escorihuela, R.M., Tobena, A., and Fernandez-Teruel, A. (1994). Environmental enrichment reverses the detrimental action of early inconsistent stimulation and increases the beneficial effects of postnatal handling on shuttlebox learning in adult rats. Behav Brain Res 61, 169-173.
35. Fant, R.V., Heishman, S.J., Bunker, E.B., and Pickworth, W.B. (1998). Acute and residual effects of marijuana in humans. Pharmacol Biochem Behav 60, 777-784.
36. Foldy, C., Lee, S.Y., Szabadics, J., Neu, A., and Soltesz, I. (2007). Cell type-specific gating of perisomatic inhibition by cholecystokinin. Nat Neurosci 10, 1128-1130.
37. Fu, J., Bottegoni, G., Sasso, O., Bertorelli, R., Rocchia, W., Masetti, M., Guijarro, A., Lodola, A., Armirotti, A., Garau, G., Bandiera, T., Reggiani, A., Mor, M., Cavalli, A., and Piomelli, D. (2011). A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci 15, 64-69.
38. Ganon-Elazar, E., and Akirav, I. (2009). Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci 29, 11078-11088.
39. Griebel, G., Moreau, J.L., Jenck, F., Martin, J.R., and Misslin, R. (1993). Some critical determinants of the behaviour of rats in the elevated plus-maze. Behav Proc 29, 37-48.
40. Hall, F.S., Huang, S., Fong, G.W., Pert, A., and Linnoila, M. (1998). Effects of isolationrearing on locomotion, anxiety and responses to ethanol in Fawn Hooded and Wistar rats. Psychopharmacology (Berl) 139, 203-209.
41. Hall, W., and Solowij, N. (1998). Adverse effects of cannabis. Lancet 352, 1611-1616.
42. Haller, J., Barna, I., Barsvari, B., Gyimesi Pelczer, K., Yasar, S., Panlilio, L.V., and Goldberg, S. (2009). Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berl) 204, 607-616.
43. Hampson, R.E., and Deadwyler, S.A. (2000). Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci 20, 8932-8942.
44. Hashimotodani, Y., Ohno-Shosaku, T., and Kano, M. (2007). Endocannabinoids and synaptic function in the CNS. Neuroscientist 13, 127-137.
45. Hauer, D., Ratano, P., Morena, M., Scaccianoce, S., Briegel, I., Palmery, M., Cuomo, V., Roozendaal, B., Schelling, G., and Campolongo, P. (2011). Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology 114, 1380-1388.
46. Hebda-Bauer, E.K., Pletsch, A., Darwish, H., Fentress, H., Simmons, T.A., Wei, Q., Watson, S.J., and Akil, H. (2010). Forebrain glucocorticoid receptor overexpression increases environmental reactivity and produces a stress-induced spatial discrimination deficit. Neuroscience 169, 645-653.
47. Hill, M.N., and Mcewen, B.S. (2010). Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry 34, 791-797.
48. Hill, M.N., Patel, S., Campolongo, P., Tasker, J.G., Wotjak, C.T., and Bains, J.S. (2010). Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci 30, 14980-14986.
49. Hillard, C.J., Edgemond, W.S., Jarrahian, A., and Campbell, W.B. (1997). Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69, 631-638.
50. Hillard, C.J., and Jarrahian, A. (2003). Cellular accumulation of anandamide: consensus and controversy. Br J Pharmacol 140, 802-808.
51. Hillard, C.J., Wilkison, D.M., Edgemond, W.S., and Campbell, W.B. (1995). Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim Biophys Acta 1257, 249-256.
52. Janero, D.R., Vadivel, S.K., and Makriyannis, A. (2009). Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies. Int Rev Psychiatry 21, 122-133.
53. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V., and Piomelli, D. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9, 76-81.
54. Katona, I. (2009). Endocannabinoid receptors: CNS localization of the CB cannabinoid receptor. Curr Top Behav Neurosci 1, 65-86.
55. Laviolette, S.R., and Grace, A.A. (2006a). Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs. J Neurosci 26, 6458-6468.
56. Laviolette, S.R., and Grace, A.A. (2006b). The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell Mol Life Sci 63, 1597-1613.
57. Lemaire, V., Aurousseau, C., Le Moal, M., and Abrous, D.N. (1999). Behavioural trait of reactivity to novelty is related to hippocampal neurogenesis. Eur J Neurosci 11, 4006-4014.
58. Mackie, K. (2005). Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol, 299-325.
59. Mackowiak, M., Chocyk, A., Dudys, D., and Wedzony, K. (2009). Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning. Neuroscience 158, 1708-1716.
60. Manwell, L.A., Satvat, E., Lang, S.T., Allen, C.P., Leri, F., and Parker, L.A. (2009). FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats. Pharmacol Biochem Behav 94, 154-162.
61. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzo, V., and Lutz, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530-534.
62. Mcgaugh, J.L. (2000). Memory--a century of consolidation. Science 287, 248-251.
63. Mcgaugh, J.L. (2004). The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27, 1-28.
64. Mcgaugh, J.L., and Roozendaal, B. (2002). Role of adrenal stress hormones in forming lasting memories in the brain. Curr Opin Neurobiol 12, 205-210.
65. Mclaughlin, R.J., and Gobbi, G. (2011). Cannabinoids and emotionality: a neuroanatomical perspective. Neuroscience.
66. Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G.M., Drago, F., and Di Marzo, V. (2009). Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 34, 593-606.
67. Mizoguchi, K., Ishige, A., Takeda, S., Aburada, M., and Tabira, T. (2004). Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function. J Neurosci 24, 5492-5499.
68. Morato, S., and Castrechini, P. (1989). Effects of floor surface and environmental illumination on exploratory activity in the elevated plus-maze. Braz J Med Biol Res 22, 707-710.
69. Moreira, F.A., Aguiar, D.C., Campos, A.C., Lisboa, S.F., Terzian, A.L., Resstel, L.B., and Guimaraes, F.S. (2009). Antiaversive effects of cannabinoids: is the periaqueductal gray involved? Neural Plast 2009, 625469.
70. Moreira, F.A., Aguiar, D.C., and Guimaraes, F.S. (2007). Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology 52, 958-965.
71. Moreira, F.A., Kaiser, N., Monory, K., and Lutz, B. (2008). Reduced anxiety-like behavior induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54, 141-150.
72. Moreira, F.A., and Wotjak, C.T. (2010). Cannabinoids and anxiety. Curr Top Behav Neurosci 2, 429-450.
73. Morris, R.G. (2006). Elements of a neurobiological theory of hippocampal function: the role of synaptic plasticity, synaptic tagging and schemas. Eur J Neurosci 23, 2829-2846.
74. Mumby, D.G., Gaskin, S., Glenn, M.J., Schramek, T.E., and Lehmann, H. (2002). Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn Mem 9, 49-57.
75. Naidu, P.S., Varvel, S.A., Ahn, K., Cravatt, B.F., Martin, B.R., and Lichtman, A.H. (2007). Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology (Berl) 192, 61-70.
76. Onaivi, E.S., Green, M.R., and Martin, B.R. (1990). Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253, 1002-1009.
77. Pacher, P., Batkai, S., and Kunos, G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58, 389-462.
78. Patel, S., and Hillard, C.J. (2006). Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318, 304-311.
79. Piomelli, D. (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4, 873-884.
80. Poucet, B. (1989). Object exploration, habituation, and response to a spatial change in rats following septal or medial frontal cortical damage. Behav Neurosci 103, 1009-1016.
81. Poucet, B. (1993). Spatial cognitive maps in animals: new hypotheses on their structure and neural mechanisms. Psychol Rev 100, 163-182.
82. Poucet, B., Chapuis, N., Durup, M., and Thinus-Blanc, C. (1986). A study of exploratory behavior as an index of spatial knowledge in hamsters. Learning & Behavior 14, 93-100.
83. Presburger, G., and Robinson, J.K. (1999). Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801. Behav Brain Res 99, 27-34.
84. Prut, L., and Belzung, C. (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463, 3-33.
85. Ranganathan, M., and D'souza, D.C. (2006). The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) 188, 425-444.
86. Ricceri, L., Colozza, C., and Calamandrei, G. (2000). Ontogeny of spatial discrimination in mice: a longitudinal analysis in the modified open-field with objects. Dev Psychobiol 37, 109-118.
87. Ricceri, L., Hohmann, C., and Berger-Sweeney, J. (2002). Early neonatal 192 IgG saporin induces learning impairments and disrupts cortical morphogenesis in rats. Brain Res 954, 160-172.
88. Ricceri, L., Usiello, A., Valanzano, A., Calamandrei, G., Frick, K., and Berger-Sweeney, J. (1999). Neonatal 192 IgG-saporin lesions of basal forebrain cholinergic neurons selectively impair response to spatial novelty in adult rats. Behav Neurosci 113, 1204-1215.
89. Robbe, D., and Buzsaki, G. (2009). Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairment. J Neurosci 29, 12597-12605.
90. Robbe, D., Montgomery, S.M., Thome, A., Rueda-Orozco, P.E., Mcnaughton, B.L., and Buzsaki, G. (2006). Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci 9, 1526-1533.
91. Robinson, L., Goonawardena, A.V., Pertwee, R.G., Hampson, R.E., and Riedel, G. (2007). The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. Br J Pharmacol 151, 688-700.
92. Roozendaal, B., and Mcgaugh, J.L. (1997). Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage. Neurobiol Learn Mem 67, 176-179.
93. Roozendaal, B., and Mcgaugh, J.L. (2011). Memory modulation. Behav Neurosci 125, 797-824.
94. Sahakian, B.J., Burdess, C., Luckhurst, H., and Trayhurn, P. (1982). Hyperactivity and obesity: the interaction of social isolation and cafeteria feeding. Physiol Behav 28, 117-124.
95. Save, E., Poucet, B., Foreman, N., and Buhot, M.C. (1992). Object exploration and reactions to spatial and nonspatial changes in hooded rats following damage to parietal cortex or hippocampal formation. Behav Neurosci 106, 447-456.
96. Scattoni, M.L., Valanzano, A., Popoli, P., Pezzola, A., Reggio, R., and Calamandrei, G. (2004). Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease. Behav Brain Res 152, 375-383.
97. Scherma, M., Medalie, J., Fratta, W., Vadivel, S.K., Makriyannis, A., Piomelli, D., Mikics, E., Haller, J., Yasar, S., Tanda, G., and Goldberg, S.R. (2008). The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Neuropharmacology 54, 129-140.
98. Sciolino, N.R., Zhou, W., and Hohmann, A.G. (2011). Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacol Res 64, 226-234.
99. Sofuoglu, M., Sugarman, D.E., and Carroll, K.M. (2010). Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol 18, 109-119.
100. Solowij, N., and Battisti, R. (2008). The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 1, 81-98.
101. Sulcova, E., Mechoulam, R., and Fride, E. (1998). Biphasic effects of anandamide. Pharmacol Biochem Behav 59, 347-352.
102. Szeligo, F., and Leblond, C.P. (1977). Response of the three main types of glial cells of cortex and corpus callosum in rats handled during suckling or exposed to enriched, control and impoverished environments following weaning. J Comp Neurol 172, 247-263.
103. Tan, H., Lauzon, N.M., Bishop, S.F., Chi, N., Bechard, M., and Laviolette, S.R. (2011). Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci 31, 5300-5312.
104. Terzian, A.L., Drago, F., Wotjak, C.T., and Micale, V. (2011). The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. Front Behav Neurosci 5, 49.
105. Thinus-Blanc, C., Bouzouba, L., Chaix, K., Chapuis, N., Durup, M., and Poucet, B. (1987). A study of spatial parameters encoded during exploration in hamsters. Journal of Experimental Psychology: Animal Behavior Processes 13, 418-427.
106. Thinus-Blanc, C., Save, E., Rossi-Arnaud, C., Tozzi, A., and Ammassari-Teule, M. (1996). The differences shown by C57BL/6 and DBA/2 inbred mice in detecting spatial novelty are subserved by a different hippocampal and parietal cortex interplay. Behav Brain Res 80, 33-40.
107. Trezza, V., Campolongo, P., Cassano, T., Macheda, T., Dipasquale, P., Carratu, M.R., Gaetani, S., and Cuomo, V. (2008a). Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl) 198, 529-537.
108. Trezza, V., Campolongo, P., Manduca, A., Morena, M., Palmery, M., and Cuomo, V. (2012). Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. Front Behav Neurosci 6:2.
109. Trezza, V., Cuomo, V., and Vanderschuren, L.J. (2008b). Cannabis and the developing brain: insights from behavior. Eur J Pharmacol 585, 441-452.
110. Ueda, N., Kurahashi, Y., Yamamoto, S., and Tokunaga, T. (1995). Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J Biol Chem 270, 23823-23827.
111. Ueda, N., Tsuboi, K., Uyama, T., and Ohnishi, T. (2011). Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. Biofactors 37, 1-7.
112. Valjent, E., Pages, C., Rogard, M., Besson, M.J., Maldonado, R., and Caboche, J. (2001). Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur J Neurosci 14, 342-352.
113. Varty, G.B., Paulus, M.P., Braff, D.L., and Geyer, M.A. (2000). Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity. Biol Psychiatry 47, 864-873.
114. Verrico, C.D., Jentsch, J.D., Roth, R.H., and Taylor, J.R. (2004). Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention. Neuropsychopharmacology 29, 522-529.
115. Vianna, M.R., Coitinho, A.S., and Izquierdo, I. (2004). Role of the hippocampus and amygdala in the extinction of fear-motivated learning. Curr Neurovasc Res 1, 55-60.
116. Viveros, M.P., Marco, E.M., and File, S.E. (2005). Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 81, 331-342.
117. Viveros, M.P., Marco, E.M., Llorente, R., and Lamota, L. (2007). The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions. Behav Pharmacol 18, 375-389.
118. Waku, K. (2006). [Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. Yakugaku Zasshi 126, 67-81.
119. Wilson, R.I., and Nicoll, R.A. (2002). Endocannabinoid signaling in the brain. Science 296, 678-682.
120. Yates, M.L., and Barker, E.L. (2009). Organized trafficking of anandamide and related lipids. Vitam Horm 81, 25-53.